These results propose the potential signaling axis of ELAVL2-SH3GL3/DNM3 in regulating aggressive MES transition in GBM, conferring favorable overall survival in SH3GL3-high and DNM3-high GBM patients (Supplementary Fig. 8e). The gene discussed is DNM3; the disease is glioblastoma.